Rivastigmine 3M Health Care Ltd (rivastigmine)
Generic
- Region
- 🇪🇺 EU
- Active substance
- rivastigmine
- Company
- 3M Health Care Limited
- Status
- Withdrawn
- Therapeutic area
- Alzheimer Disease
- CHMP opinion
- Thu 23 Jan 2014
- EU approval
- Thu 03 Apr 2014
- Designations
- Generic
- Application
- EMEA/H/C/003824
- ATC
- N06DA03
- Official record
- www.ema.europa.eu
Indication
Symptomatic treatment of mild to moderately severe Alzheimer's dementia.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Rivastigmine Hexal Authorised · Hexal AG
- 🇪🇺 Rivastigmine Sandoz Authorised · Sandoz GmbH
- 🇪🇺 Rivastigmine 1 A Pharma Authorised · 1 A Pharma GmbH
- 🇪🇺 Exelon Authorised · Novartis Europharm Limited
- 🇪🇺 Nimvastid Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Rivastigmine Actavis Authorised · Actavis Group PTC ehf
- 🇪🇺 Prometax Authorised · Almirall, S.A.
- 🇪🇺 Rivastigmine Teva Withdrawn · Teva Pharma B.V.
Follow Rivastigmine 3M Health Care Ltd
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.